Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia

Overview

This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the quality of care for people with schizophrenia.

Full Title of Study: “Consumer Internet Education About Mental Health Quality”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2007

Detailed Description

Schizophrenia is a disabling mental disorder that causes hallucinations and delusions in those affected by it. Research has proven that certain treatment methods are more effective in treating schizophrenia than others. However, not everyone with schizophrenia responds to treatment in the same way, and not all physicians use the same treatment methods. Educating individuals with schizophrenia about all treatments available instead of only the treatments they are receiving may improve the quality of care and lead to better correlation between treatment and quality standards. This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the congruence between expected quality of treatment and treatment received among people with schizophrenia. Participants in this open label study will be randomly assigned to either use the interactive website or read written materials and watch a video. All three sources will contain information about evidence-based treatment recommendations. Both groups will complete a brief interview before performing their assigned tasks. Upon completion of the interview, participants in the written materials/video group will be given the reading material and will watch a 20-minute video. Participants in the web-user group will sit with a laptop computer, answer questions about themselves and their treatment, receive feedback on care that may be inconsistent with current recommendations, and receive suggestions on how to discuss this with their physicians. Participants in clinical settings will be asked to allow their next clinician visit to be audiotaped to assess outcomes. A phone interview will be conducted with all participants 2 months following the intervention to assess treatment satisfaction and other outcomes. Medical records will be reviewed to collect treatment information 6 months before and after the intervention.

Interventions

  • Behavioral: Interactive Website on management of schizophrenia
    • Participants in the web-user group will sit with a laptop computer, answer questions about themselves and their treatment, receive feedback on care that may be inconsistent with current recommendations, and receive suggestions on how to discuss this with their physicians.
  • Behavioral: Written materials and video on management of schizophrenia
    • Participants in the written materials/video group will be given the reading material and will watch a 20-minute video.

Arms, Groups and Cohorts

  • Experimental: 1
    • Participants will use the interactive website
  • Active Comparator: 2
    • Participants will read written materials and watch a video

Clinical Trial Outcome Measures

Primary Measures

  • Concordance of treatment with evidence-based recommendations
    • Time Frame: Measured at Month 6

Secondary Measures

  • Patient engagement in dialogue with clinician about schizophrenia management issues
    • Time Frame: Measured at visit immediately following intervention/control condition
  • Clinician satisfaction with interaction with patient
    • Time Frame: Measured at visit immediately following intervention/control condition
  • Patient satisfaction with interaction with clinician
    • Time Frame: Measured at visit immediately following intervention/control condition and at Month 2 post-intervention
  • Symptoms of psychosis
    • Time Frame: Measured at Month 2 post-intervention
  • Symptoms of depression
    • Time Frame: Measured at Month 2 post-intervention
  • Quality of life ratings
    • Time Frame: Measured at Month 2 post-intervention
  • Adherence to care regimen
    • Time Frame: Measured at Month 2 post-intervention
  • Satisfaction with outcomes of care
    • Time Frame: Measured at Month 2 post-intervention

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosis of schizophrenia – Able to read and write English – Scheduled to see a participating clinician at one of the study sites Exclusion Criteria:

  • N/A

Gender Eligibility: All

Minimum Age: 13 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Johns Hopkins Bloomberg School of Public Health
  • Collaborator
    • National Institute of Mental Health (NIMH)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Donald Steinwachs, Professor – Johns Hopkins Bloomberg School of Public Health
  • Overall Official(s)
    • Donald M. Steinwachs, PhD, Principal Investigator, Johns Hopkins Bloomberg School of Public Health

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.